Lawsuits News 17 October 2025

AMD Stock Today, December 11, 2025: Premarket Price, Lawsuit Shock and New AI Growth Forecasts

Advanced Micro Devices (AMD) is starting Thursday’s session under pressure. Before the opening bell on December 11, 2025, the stock is trading slightly lower in premarket dealings as investors weigh fresh lawsuits tied to Russian weapons, a softening tone on

11 December 2025

AI Technology·AMD·Financial News·Lawsuits·Stock Market

Dow Chemical Stock (DOW) in December 2025: Dividend Cut, Lawsuits and 2026 Recovery Hopes

Dow Chemical stock – technically Dow Inc. (NYSE: DOW), the successor to The Dow Chemical Company – is limping into the end of 2025 after one of its roughest years since the pandemic. At Friday’s close on 5 December 2025,

7 December 2025

Dividends·Lawsuits·Stock Market

Coca-Cola (KO) Stock Outlook December 2025: Dividend King Faces Lawsuit Risk but Analysts Still See Upside

Data and news current through the close on December 4, 2025. This article is for informational purposes only and is not investment advice. Coca-Cola stock today: price, performance and valuation The Coca-Cola Company (NYSE: KO) closed at $70.54 on December

4 December 2025

Dividends·Investment Analysis·Lawsuits·Market Outlook·Stocks

Synopsys (SNPS) Stock on December 3, 2025: Nvidia’s $2 Billion Bet, Class‑Action Lawsuits and New Analyst Forecasts

Synopsys, Inc. (NASDAQ: SNPS) is back in the market spotlight after a volatile few months. On Wednesday, December 3, 2025, the stock extended a sharp rebound driven by Nvidia’s $2 billion strategic investment, even as fresh class‑action lawsuits and mixed

3 December 2025

Analyst Forecasts·Lawsuits·NVIDIA·Stock Market

Bristol-Myers Squibb (BMY) Stock Today: Celgene Lawsuit Shock, ASH 2025 Momentum and 2026 Forecasts

On December 2, 2025, Bristol-Myers Squibb (NYSE: BMY) found itself at the center of two very different storylines: a revived $6.7 billion Celgene lawsuit and strong hematology data at ASH 2025. Together with a hefty dividend and low valuation multiples,

3 December 2025

Biotech News·Investment Analysis·Lawsuits·Pharmaceuticals·Stock Market

Bristol-Myers Squibb (BMY) Stock Today: Lawsuit Shock, Breyanzi Momentum and 2026 Forecast

Bristol-Myers Squibb (NYSE: BMY) has suddenly become one of the most eventful big pharma names to watch as of December 1, 2025. A major lawsuit has been allowed to proceed, new cell therapy approvals are landing, hematology data at ASH

2 December 2025

Investment Analysis·Lawsuits·Market Forecast·Pharmaceutical Industry·Stocks

Standard Chartered PLC Hit by US$2.7bn 1MDB Lawsuit as It Accelerates Capital, Green Finance and Digital-Asset Push – 24 November 2025

On 24 November 2025, Standard Chartered PLC finds itself in a paradoxical position: facing a major legal challenge in Singapore linked to the 1MDB scandal, while simultaneously showcasing strength in capital, sustainability, and digital innovation across its key markets. From

24 November 2025

Banking·Corporate Strategy·Lawsuits

Uber Stock Poised to Soar? Guggenheim’s $140 Price Target Explained

Uber Stock Today, November 20, 2025: AI Pay Lawsuit Triggers Sell‑Off Despite Robot Delivery Deal

Uber Technologies (NYSE: UBER) had a volatile session on Thursday, 20 November 2025, as investors weighed a fresh European legal challenge to the company’s AI‑driven pay systems against upbeat news on automation, travel partnerships and still‑bullish Wall Street views. By

20 November 2025

AI Technology·Business Analysis·Lawsuits·Stock Market·Uber News

Broadcom’s $10B AI Chip Deal Ignites Stock Surge – What’s Powering This Tech Giant’s Boom

Broadcom Stock Today (Nov. 20, 2025): AVGO Rallies on AI Launch, Nvidia Results and Fidelity Lawsuit

Broadcom Inc. (NASDAQ: AVGO) is back in the spotlight on Thursday, November 20, 2025, as the stock extends a sharp rebound driven by powerful AI infrastructure news, Nvidia’s blockbuster earnings, and rising legal drama around VMware. On Wednesday, AVGO jumped

20 November 2025

AI Technology·Company News·Investment Analysis·Lawsuits·Stock Market

Beyond Meat (BYND) Stock Skyrockets 50% Amid Meme Mania – Turnaround or Dead Cat Bounce?

Beyond Meat Stock Crashes to $1 as Shareholders Face Massive Dilution and Lawsuit Risks – 19 November 2025

Published: 19 November 2025 Beyond Meat’s dramatic late‑October meme‑stock rally has given way to a brutal reality check. On 19 November 2025, the plant‑based meat pioneer is trading around $1 per share, down roughly 40% just this month and about 73% year‑to‑date, hovering near

19 November 2025

Financial Analysis·Lawsuits·Stock Market

Genius Group (GNS) Soars on Market‑Manipulation Lawsuit: What Today’s 17 November 2025 Rally Really Means

Genius Group Limited (NYSE American: GNS) is back in the spotlight today after its stock spiked more than 35–40% in U.S. pre‑market trading, driven by fresh attention on a newly filed $250 million federal securities class action lawsuit against Citadel

17 November 2025

Financial News·Investing·Lawsuits·Market Analysis·Stock Market

Kenvue (KVUE) Stock Plummets to Record Low Amid Talc Lawsuit and Tylenol Scare

Stock Hits a 52-Week Low on Legal Woes Kenvue’s shares collapsed to an all-time low since their mid-2023 IPO, closing around $14 after Thursday’s 13.2% plunge Stocktwits. The one-day drop – Kenvue’s worst on record – was triggered by headline

17 October 2025

Financial Analysis·Health News·Lawsuits·Pharmaceutical Industry·Stock Market

Lawsuits News 17 October 2025 - 11 December 2025